Purdue, Mark P.
National Cancer Institute (NCI),
United States
2024 Rank: 88316
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 2929 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88316 | 88089 |
| Total Cites | 1993 | 2259 |
| H-index | 19 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 71 | 85 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 192 | 215 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1717 | 1861 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
11.78%
|
|
Purdue, Mark P.
National Cancer Institute (NCI),
United States
2023 Rank: 71231
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 2581 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71231 | 74190 |
| Total Cites | 2139 | 2371 |
| H-index | 18 | 20 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 99 | 103 |
| Number of Single+First+Last Authored Papers | 91 | 91 |
| Total Cites to Single+First+Last Authored Papers | 201 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1822 | 1935 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
9.78%
|
|
Purdue, Mark P.
National Cancer Institute (NCI),
2021 Rank: 61029
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 2208 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61029 | 60090 |
| Total Cites | 2912 | 3386 |
| H-index | 22 | 24 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 144 | 162 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 318 | 353 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2490 | 2748 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
14.00%
|
|
Purdue, Mark P.
National Cancer Institute,
United States
2020 Rank: 84760
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Epidemiology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 170 out of 9540 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84760 | 76406 |
| Total Cites | 1907 | 2319 |
| H-index | 18 | 21 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 101 | 122 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 225 | 256 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1641 | 1863 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
17.77%
|
|